Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3

Metabolism: Clinical and Experimental · Published 2026-03-24 · DOI 10.1016/j.metabol.2026.156600

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.metabol.2026.156600

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023 · Metabolism: Clinical and Experimental · 2026 · Cites or is cited by this article · Same journal
• Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records · The Lancet Public Health · 2023 · Cites or is cited by this article
• Dynamic regulation of circulating endotrophin by changes in fat mass in humans · Metabolism: Clinical and Experimental · 2026 · Same journal
• Cytochrome P450 2E1 deficiency alters hepatic mitochondria and impairs liver organoid formation · Metabolism: Clinical and Experimental · 2026 · Same journal
• Metabolomic signatures of type 2 diabetes and mortality: Methodological considerations and unresolved questions · Metabolism: Clinical and Experimental · 2026 · Same journal
• STAU1 fine-tunes adipose thermogenesis by regulating Ucp1 mRNA stability · Metabolism: Clinical and Experimental · 2026 · Same journal
• Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitis · Metabolism: Clinical and Experimental · 2026 · Same journal
• The endogenous ghrelin antagonist, LEAP2, accelerates puberty onset in conditions of early obesity · Metabolism: Clinical and Experimental · 2026 · Same journal
• Muscle-derived ANXA2 promotes hepatic steatosis by activating SREBP1c-mediated de novo lipogenesis · Metabolism: Clinical and Experimental · 2026 · Same journal
• The effects of acute ketone monoester supplementation on brain insulin responsiveness and cognitive performance: Results of a randomized, double-blind, placebo-controlled crossover trial in older men with overweight · Metabolism: Clinical and Experimental · 2026 · Same journal